JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewington, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewington, V. J.

Bone-Seeking Radionuclides For Therapy

Val J. Lewington, BM, MSc, FRCP

Royal Marsden Hospital, Sutton, England, United Kingdom



View larger version (62K):

[in a new window]
  		FIGURE 1. (A) Posterior whole-body 99mTc-MDP bone image of patient with hormone-refractory prostate cancer. (B) Pain sites (cross-hatched) correlate exactly with foci of increased osteoblastic activity.

 


View larger version (36K):

[in a new window]
  		FIGURE 2. Unsuspected bilateral vesicoureteric junction obstruction in advanced prostate cancer. Lumbar discomfort was relieved by ureteric stenting. Targeted radionuclide therapy would not have controlled dominant symptom, and poor excretion might have increased renal and whole-body doses.

 


View larger version (31K):

[in a new window]
  		FIGURE 3. 99mTc-MDP bone image of patient with early metastases.

 


View larger version (33K):

[in a new window]
  		FIGURE 4. 99mTc-MDP bone image of patient with diffuse metastases.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.